Abu Dhabi Leads Precision Medicine for Alzheimer’s with Groundbreaking Pharmacogenomics Integration
In a regional first, the Department of Health – Abu Dhabi (DoH), in collaboration with M42’s Biogenix Lab, has introduced APOE E4 genetic testing into its pharmacogenomics (PGx) reports, marking a significant advancement in the personalised care of Alzheimer’s disease.…